The effect of alpha and beta adrenergic blockade on thoracic duct lymph flow in normovolemic and hypovolemic dogs.
D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D000318:Adrenergic beta-Agonists / Q000494:pharmacology; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000818:Animals; D001775:Blood Circulation; D001794:Blood Pressure; D002395:Catecholamines / Q000378:metabolism; D004285:Dogs; D005260:Female; D007022:Hypotension; D007545:Isoproterenol / Q000494:pharmacology; D008196:Lymph / Q000502:physiology; D008297:Male; D010424:Pentobarbital; D010646:Phentolamine / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D011674:Pulse; D013565:Sympatholytics; D013566:Sympathomimetics / Q000494:pharmacology*; D013897:Thoracic Duct / Q000187:drug effects*; D014690:Venous Pressure
D000317:Adrenergic alpha-Antagonists; D000318:Adrenergic beta-Agonists; D000319:Adrenergic beta-Antagonists; D002395:Catecholamines; D013565:Sympatholytics; D013566:Sympathomimetics; D011433:Propranolol; D010424:Pentobarbital; D007545:Isoproterenol; D010646:Phentolamine